US 8501695
Tissue kallikrein for the treatment of diseases associated with amyloid protein
granted A61KA61K31/14A61K31/407
Quick answer
US patent 8501695 (Tissue kallikrein for the treatment of diseases associated with amyloid protein) held by DiaMedica Inc. expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DiaMedica Inc.
- Grant date
- Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/14, A61K31/407, A61K31/685, A61K36/16